Stada buys Takeda drug bundle to boost Russia business
Share:
(Reuters) - Germany's Stada on Tuesday agreed to purchase over-the-counter and prescription drugs units from Japan's largest drugmaker Takeda for $660 million (£512 million), part of two deals that boost its Russian and Eastern European footprint. The portfolio, which Takeda is selling in a push to slash debt after its $59 billion purchase of Shire, includes drugs sold exclusively in Russia, Georgia and a number of countries from within the Commonwealth of Independent States, the companies..